AON
54
2
SE
60
-3
TGT
45
-4
HAL
48
-3
SNA
70
-5
HBI
58
3
VZ
44
4
XOM
42
-6
CMG
66
-4
ORCL
63
-4
MAR
63
-5
M
31
-3
STT
64
2
R
70
-3
TSN
50
-2
DOV
65
-4
FFIV
66
-4
UNH
57
-2
NWSA
62
-7
MCO
71
-7
AON
54
2
SE
60
-3
TGT
45
-4
HAL
48
-3
SNA
70
-5
HBI
58
3
VZ
44
4
XOM
42
-6
CMG
66
-4
ORCL
63
-4
MAR
63
-5
M
31
-3
STT
64
2
R
70
-3
TSN
50
-2
DOV
65
-4
FFIV
66
-4
UNH
57
-2
NWSA
62
-7
MCO
71
-7
Financhill
Back

Entegris Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
48

ENTG
Entegris

Last Price:
99.51
Seasonality Move:
8.7%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
42.87
Seasonality Move:
17.03%
Sell
48
Entegris (ENTG) is a Sell

Is Entegris a Buy, Sell or Hold?

  • The current Entegris [ENTG] share price is $97.67. The Score for ENTG is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • ENTG is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ENTG Stock Price Chart

What is Entegris's stock price today?

  • The Entegris share price today is $97.67
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ENTG is experiencing selling pressure, which indicates risk of future bearish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

ENTG Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.61 Sell
Relative Strength Index (14 RSI): 37.43 Sell
Chaikin Money Flow: -3103335 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (101.92 - 107.58) Sell
Bollinger Bands (100): (102.41 - 127.25) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

ENTG Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 104.16 Sell
20-day SMA: 104.51 Sell
50-day SMA: 107.77 Sell
200-day SMA: 123.76 Sell
8-day EMA: 102.97 Sell
20-day EMA: 104.66 Sell
50-day EMA: 107.9 Sell
200-day EMA: 115.59 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Entegris Earnings Growth & ENTG Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.37 per share, and an increase next year of $0.88 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.35 per share, and an increase next year of $0.56 per share.

Entegris Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):